Found 58 matching trials
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma PHASE2 This Single-arm, multicentre, phase 2 trial aims determine the activity and...
Show More Location
Border Medical Oncology Research Unit
Learn More & Join Trial
Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone PHASE2 To determine how safe and effective denosumab is in treating patients with ...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults PHASE1 A Dual-center , Randomized, double-blinded and Parallel-controlled Study to...
Show More Location
Haikou People's Hospital
Learn More & Join Trial
A Study to Evaluate LY01011 and Xgeva® in Healthy Adults PHASE1 A randomized, double-blind, single-dose, parallel-group study to compare th...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease PHASE4 This study will estimate the total time for the preparation and administrat...
Show More Location
Multiple Locations
Learn More & Join Trial
Reduced Dose-density of Denosumab for Unresectable GCTB PHASE2 This study is a multi-center, multi-national, open label, single arm phase ...
Show More Location
IRCCS Istituto Ortopedico Rizzoli
Learn More & Join Trial
Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients PHASE2 This is a randomized, 2-arm phase II, placebo-controlled, multi-center stud...
Show More Location
IIIrd Medical Department, Private Medical University Hospital Salzburg
Learn More & Join Trial
Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS) PHASE2 Bone metastases are common in Non-Small Cell Lung Cancer (NSCLC). They most...
Show More Learn More & Join Trial
A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC) PHASE2 This is a Phase II, open label, multicentre, multi-arm, study to evaluate t...
Show More Location
Providence Medical Foundation
Learn More & Join Trial
Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies PHASE3 Multicenter, randomized, open-label, 2-arm, parallel-group, phase III study...
Show More Location
Centre Leon Berard
Learn More & Join Trial